China conditionally approves four self-developed COVID-19 vaccines: official
Xinhua |
Updated: 2021-02-26 20:09
Share
Share - WeChat
BEIJING - China has granted conditional market approval to four self-developed COVID-19 vaccines, Minister of Science and Technology Wang Zhigang said Friday.
China has adopted five technological approaches in developing COVID-19 vaccines. China now has 17 self-developed COVID-19 vaccines undergoing clinical trials, with seven undergoing phase-3 clinical trials, Wang told a press conference held in Beijing.
China has also included 11 drugs and treatment methods in its diagnosis and treatment plan for COVID-19, Wang added.
- China's Global Governance Initiative receives positive feedback at forum
- China's Xizang sees steady tourism growth in 2025
- First-of-its-kind pearl auction held utilizing Hainan FTP
- Agarwood exhibition steeps Shanghai museum in fragrance
- The Fujian Coast Guard conducts regular law enforcement patrol in the waters near Jinmen
- IP protection for new fields to improve
